Completed OBSERVATIONAL NCT00186602

Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?

Does a Peer Navigator Improve Quality of Life at Diagnosis?

Sponsor: Amgen

Updated 8 times since 2017 Last updated: Nov 20, 2019 Started: Jul 1, 2000 Primary completion: Nov 30, 2006 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00186602, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Amgen, it has been updated 8 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2020 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Dec 2019 — Dec 2020 [monthly]

Completed

Status: Unknown Status → Completed · Phase: PHASE2 → None
Jun 2018 — Dec 2019 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jul 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen
California Breast Cancer Research Program
Genentech, Inc.
Google LLC.
Johnson & Johnson
Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santa Cruz, United States